BlackSky Raises 2026 Guidance on Gen-3 Demand; Cash Conversion Remains Key

What happened

BlackSky raised its 2026 revenue and adjusted EBITDA outlook after Q1 results, citing accelerating Gen-3 and AI demand. Q1 performance showed revenue growth, but the DeepValue report flags that FY2025 adjusted EBITDA was only $0.9M and free cash flow remained negative in Q4'25. The raised guidance validates the bull case of international subscription scaling, but the stock still trades at $24.30 with a WAIT rating pending Q2'26 evidence of EOCL tasking recovery. Management's optimism must be weighed against the 8-K/A corrections to working capital and the risk that backlog conversion does not translate into cash. The next quarterly filing will be critical to confirm whether Gen-3 capacity is converting into sustained revenue and improving cash flow.

Implication

The raised guidance supports the bull case but does not resolve the core investment thesis hinge: cash conversion and U.S. budget clarity. Investors should wait for Q2'26 evidence that backlog is converting into sustained quarterly revenue above $32M and that free cash flow turns positive. If Q2 confirms improving working capital and EOCL tasking recovery, the WAIT rating could be upgraded. However, if contract assets re-inflate or U.S. demand remains uncertain, the downside scenario of $16 becomes more likely. Position sizes should remain modest until the June checkpoints are met.

Thesis delta

The raised guidance nudges the thesis toward the bull scenario, but the critical gate remains Q2'26 cash conversion and U.S. budget clarity. If Q2 confirms sustained quarterly revenue above $32M and improving free cash flow, the WAIT rating could be upgraded. Conversely, if working capital re-inflates or EOCL fails to materialize, the bear case of $16 becomes more likely.